Sai Life Sciences receive Certificate of Inspection from Japan PMDA
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
Subscribe To Our Newsletter & Stay Updated